Financial results - ENDOCRINOLOGIE - OFFICE SRL

Financial Summary - Endocrinologie - Office Srl
Unique identification code: 31531665
Registration number: J2013000435024
Nace: 8622
Sales - Ron
32.692
Net Profit - Ron
-1.899
Employees
1
Open Account
Company Endocrinologie - Office Srl with Fiscal Code 31531665 recorded a turnover of 2024 of 32.692, with a net profit of -1.899 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Endocrinologie - Office Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 8.649 14.296 16.706 21.072 29.452 26.370 26.210 30.383 17.640 32.692
Total Income - EUR 8.649 14.298 16.707 21.057 29.452 26.370 26.210 30.383 17.599 51.730
Total Expenses - EUR 14.329 8.872 10.556 10.814 14.529 15.042 23.495 23.347 34.194 52.108
Gross Profit/Loss - EUR -5.680 5.426 6.151 10.243 14.924 11.328 2.715 7.036 -16.596 -378
Net Profit/Loss - EUR -5.939 5.141 5.984 10.032 14.629 11.076 2.485 6.766 -16.763 -1.899
Employees 2 2 2 2 2 2 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 86.4%, from 17.640 euro in the year 2023, to 32.692 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Endocrinologie - Office Srl

Rating financiar

Financial Rating -
ENDOCRINOLOGIE - OFFICE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Endocrinologie - Office Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endocrinologie - Office Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Endocrinologie - Office Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endocrinologie - Office Srl - CUI 31531665

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 90 0 0 0 0 29.882 24.907 17.297 21.644 45.864
Current Assets 1.718 625 2.646 4.254 18.754 28.003 25.025 35.899 10.334 1.030
Inventories 0 0 131 0 0 0 65 0 51 0
Receivables 385 373 1.880 3.835 1.926 3.978 400 326 603 0
Cash 1.333 251 635 419 16.828 24.025 24.560 35.573 9.680 1.030
Shareholders Funds -20.088 -14.742 -8.509 1.680 16.276 27.044 28.929 35.785 5.753 3.821
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 21.895 15.367 11.155 2.574 2.478 30.841 21.002 17.411 26.224 43.073
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.030 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 1.030 euro.
The company's Equity was valued at 3.821 euro, while total Liabilities amounted to 43.073 euro. Equity decreased by -1.900 euro, from 5.753 euro in 2023, to 3.821 in 2024.

Risk Reports Prices

Reviews - Endocrinologie - Office Srl

Comments - Endocrinologie - Office Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.